Covestor LTD Annovis Bio, Inc. Transaction History
Covestor LTD
- $170 Million
- Q2 2025
A detailed history of Covestor LTD transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Covestor LTD holds 2,339 shares of ANVS stock, worth $5,964. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,339
Previous 1,876
24.68%
Holding current value
$5,964
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ANVS
# of Institutions
54Shares Held
2.13MCall Options Held
88.1KPut Options Held
188K-
Vanguard Group Inc Valley Forge, PA697KShares$1.78 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA183KShares$467,3810.0% of portfolio
-
Two Sigma Investments, LP New York, NY166KShares$423,8580.0% of portfolio
-
Ubs Group Ag161KShares$410,2330.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA128KShares$325,6470.0% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $20.8M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...